Compare NBTX & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | PNTG |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | France | United States |
| Employees | N/A | 9700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2018 | 2019 |
| Metric | NBTX | PNTG |
|---|---|---|
| Price | $32.78 | $32.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $26.00 | ★ $36.83 |
| AVG Volume (30 Days) | 39.7K | ★ 282.2K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 0.84 |
| Revenue | N/A | ★ $947,705,000.00 |
| Revenue This Year | N/A | $24.93 |
| Revenue Next Year | $11.73 | $7.52 |
| P/E Ratio | ★ N/A | $40.60 |
| Revenue Growth | N/A | ★ 36.31 |
| 52 Week Low | $2.99 | $21.74 |
| 52 Week High | $41.89 | $35.25 |
| Indicator | NBTX | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 57.18 | 51.94 |
| Support Level | $20.11 | $27.34 |
| Resistance Level | N/A | $35.00 |
| Average True Range (ATR) | 2.69 | 1.76 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 47.72 | 62.41 |
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.